LOXL2 and hepatocellular carcinoma: In HCC cells, several studies showed that the miR-29-3p-family acted as tumor-suppressive miRNAs via negative control of several oncogenic targets, e.g., IGF2BP1, RPS15A and LOXL2 [35,36,37].